<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04149028</url>
  </required_header>
  <id_info>
    <org_study_id>POFPRP</org_study_id>
    <nct_id>NCT04149028</nct_id>
  </id_info>
  <brief_title>Platelet Rich Plasma Injection Into Ovary of Patients With Premature Ovarian Insufficiency</brief_title>
  <official_title>Platelet Rich Plasma Injection Into Ovary of Patients With Premature Ovarian Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All encountered cases with POI will be assessed and examined then investigated. Eligible
      cases will be included in the study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be subjected to injection of autologous PRP inside the ovary about 0.5-1 mml by
      laparoscopy
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All eligible patient will recieve the treatment with PRP</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resumption of ovarian hormonal function</measure>
    <time_frame>3-6 months</time_frame>
    <description>Measurement of Estradiol level on Day 3 of cycle</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resumption of ovarian folliclugenesis</measure>
    <time_frame>3-6 months</time_frame>
    <description>Assessment of the presence of oocytes by trans vaginal ultrasound on day 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resumption of menstruation</measure>
    <time_frame>3-6 months</time_frame>
    <description>Occurrence of Menstruation after secondary amenrorrhea by questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertility potential</measure>
    <time_frame>3-6 months</time_frame>
    <description>Potential to get pregnant after ICSI procedure</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Premature Ovarian Failure</condition>
  <arm_group>
    <arm_group_label>PRP injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection of PRP inside ovary by the assistance of laparoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PRP injection inside the ovary by laparoscoy. The injection volume is 2 ml</intervention_name>
    <description>intraovarian injection of 2 mml of PRP by laparoscopic guide</description>
    <arm_group_label>PRP injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premature ovarian insufficiency diagnosed by:

          -  FSH&gt; 40 Amenorrhea Menopuasal symptoms Infertility

        Exclusion Criteria:

          -  Refusal to participate Secondary POI due chemotherapy, surgery, or radiotherapy
             Previous treatment with PRP
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Adel Elgergawy</last_name>
    <phone>+201002057250</phone>
    <email>dradelali775@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Adel Elgergawy</name>
      <address>
        <city>Tanta</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adel Elgergawy</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 30, 2019</study_first_submitted>
  <study_first_submitted_qc>October 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>January 12, 2020</last_update_submitted>
  <last_update_submitted_qc>January 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Ayman S Dawood, MD</investigator_full_name>
    <investigator_title>Lecturer of Obstetrics and gynecology</investigator_title>
  </responsible_party>
  <keyword>Premature ovarian insuffiency</keyword>
  <keyword>Infertility</keyword>
  <keyword>PRP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Primary Ovarian Insufficiency</mesh_term>
    <mesh_term>Menopause, Premature</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>we will decide later</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

